La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Elanor Investors Group Croissance future

Future contrôle des critères 3/6

Le chiffre d'affaires de Elanor Investors Group devrait diminuer de 27.3% par an, tandis que ses bénéfices annuels devraient croître de 71.5% par an. Le BPA devrait croître de , augmenter de 76.2% par an.

Informations clés

71.5%

Taux de croissance des bénéfices

76.2%

Taux de croissance du BPA

Hospitality croissance des bénéfices	14.2%
Taux de croissance des recettes	-27.3%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	23 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Elanor Investors Group (ASX:ENN) Will Pay A Dividend Of A$0.0475

Dec 22

There's Reason For Concern Over Elanor Investors Group's (ASX:ENN) Price

Dec 14

Shareholders May Be More Conservative With Elanor Investors Group's (ASX:ENN) CEO Compensation For Now

Oct 18

Elanor Investors Group (ASX:ENN) Use Of Debt Could Be Considered Risky

Jun 28

When Should You Buy Elanor Investors Group (ASX:ENN)?

Jun 16

These 4 Measures Indicate That Elanor Investors Group (ASX:ENN) Is Using Debt In A Risky Way

May 10

Prévisions de croissance des bénéfices et des revenus

ASX:ENN - Estimations futures des analystes et données financières antérieures (AUD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2026	68	20	N/A	N/A	1
6/30/2025	65	18	N/A	N/A	1
6/30/2024	59	17	N/A	N/A	1
12/31/2023	147	-26	-69	10	N/A
9/30/2023	149	-21	-62	14	N/A
6/30/2023	151	-17	-55	18	N/A
3/31/2023	153	-15	-39	17	N/A
12/31/2022	154	-13	-24	16	N/A
9/30/2022	135	-13	-25	6	N/A
6/30/2022	115	-12	-27	-5	N/A
3/31/2022	106	-4	-19	-5	N/A
12/31/2021	97	4	-12	-5	N/A
9/30/2021	97	4	-2	5	N/A
6/30/2021	98	3	9	15	N/A
3/31/2021	85	0	-5	13	N/A
12/31/2020	72	-3	-20	12	N/A
9/30/2020	70	-7	-76	10	N/A
6/30/2020	69	-10	-133	7	N/A
12/31/2019	89	-11	-117	8	N/A
9/30/2019	106	-3	-64	5	N/A
6/30/2019	122	5	-12	3	N/A
12/31/2018	118	3	-5	1	N/A
9/30/2018	97	-2	-60	3	N/A
6/30/2018	76	-7	-116	5	N/A
12/31/2017	52	-2	-111	8	N/A
9/30/2017	59	0	N/A	10	N/A
6/30/2017	66	1	N/A	13	N/A
3/31/2017	91	1	N/A	13	N/A
12/31/2016	86	-1	N/A	13	N/A
9/30/2016	78	-1	N/A	13	N/A
6/30/2016	69	-1	N/A	14	N/A
3/31/2016	66	1	N/A	13	N/A
12/31/2015	62	2	N/A	12	N/A
9/30/2015	59	0	N/A	9	N/A
6/30/2015	56	-3	N/A	7	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: ENN devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 2.4% ).

Bénéfices vs marché: ENN devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: ENN devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Les revenus de ENN devraient diminuer au cours des 3 prochaines années ( -31.6% par an).

Croissance élevée des revenus: Les revenus de ENN devraient diminuer au cours des 3 prochaines années ( -31.6% par an).

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de ENN devrait être élevé dans 3 ans

Elanor Investors Group Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Price target decreased by 18% to AU$1.76

Price target decreased to AU$2.36

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 31 December 2021

Price target increased to AU$2.46

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 30 June 2021

Price target raised to AU$2.03

Recent updates

Elanor Reportedly Taps Denison Partners for Hotel Sale

New major risk - Financial position

Now 76% overvalued

MD, CEO & Director recently bought AU$98k worth of stock

Now 23% undervalued after recent price drop

Price target decreased by 18% to AU$1.76

First half 2024 earnings released: AU$0.091 loss per share (vs AU$0.003 loss in 1H 2023)

High number of new directors

Elanor Investors Group (ASX:ENN) Will Pay A Dividend Of A$0.0475

Elanor Investors Group Provides Distribution Guidance for the Six Months Ending December 31, 2023, Payable on February 29, 2024

There's Reason For Concern Over Elanor Investors Group's (ASX:ENN) Price

Shareholders May Be More Conservative With Elanor Investors Group's (ASX:ENN) CEO Compensation For Now

Elanor Investors Group, Annual General Meeting, Oct 25, 2023

Elanor Investors Group Announces Board Changes

New minor risk - Financial position

Full year 2023 earnings: Revenues exceed analyst expectations

Elanor Investors Group Appoints Victor Rodriguez as A Non-Executive Director, Effective 7 July 2023

Elanor Investors Group (ASX:ENN) Use Of Debt Could Be Considered Risky

New minor risk - Shareholder dilution

First half 2023 earnings released: AU$0.034 loss per share (vs AU$0.009 profit in 1H 2022)

Elanor Investors Group (ASX:ENN) acquired Riverton Forum shopping centre in Perth for $98.8 million on December 21, 2022.

Elanor Hotel Accommodation Fund, managed by Elanor Investors Group (ASX : ENN) agreed to acquire Chateau Yering Hotel Management Pty Ltd.

Now 22% undervalued after recent price drop

Price target decreased to AU$2.36

Now 21% undervalued after recent price drop

Elanor Investors Group Announces Establishment of the Tweed Mall Mixed-Use Real Estate Fund

Elanor Investors Group, Annual General Meeting, Oct 27, 2022

Now 22% undervalued

Full year 2022 earnings released: AU$0.048 loss per share (vs AU$0.029 profit in FY 2021)

Now 21% undervalued after recent price drop

Now 24% undervalued after recent price drop

Elanor Investors Group Announces Distribution for the Six Month Ending June 30, 2022, Payable on August 31, 2022

When Should You Buy Elanor Investors Group (ASX:ENN)?

Now 21% undervalued after recent price drop

These 4 Measures Indicate That Elanor Investors Group (ASX:ENN) Is Using Debt In A Risky Way

Elanor Investors Group Announces the Establishment of the Harris Street Fund

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued after recent price drop

Elanor Investors Group Announces for the Six Months Ended December 31, 2021, Payable on February 28, 2022

Elanor Investors Group to Report First Half, 2022 Results on Feb 21, 2022

Now 20% undervalued

Upcoming dividend of AU$0.088 per share

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 31 December 2021

Full year 2021 earnings released: EPS AU$0.029 (vs AU$0.09 loss in FY 2020)

Price target increased to AU$2.46

Elanor Investors Group's (ASX:ENN) Earnings Aren't As Good As They Appear

Full year 2021 earnings released: EPS AU$0.039 (vs AU$0.10 loss in FY 2020)

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 30 June 2021

Elanor Investors Group (ASX:ENN) Has No Shortage Of Debt

Elanor Healthcare Real Estate Fund, managed by Elanor Investors Group (ASX:ENN) acquired Broadway Medical Centre in Ellenbrook for AUD 12 million.

Estimating The Intrinsic Value Of Elanor Investors Group (ASX:ENN)

What Is Elanor Investors Group's (ASX:ENN) Share Price Doing?

Is Elanor Investors Group (ASX:ENN) A Risky Investment?

Price target raised to AU$2.03

New 90-day low: AU$1.48

Non-Executive Director has left the company

Elanor Investors Group Announces Resignation of Kin Song Lim as a Non-Executive Director of Elanor Investors Group, Elanor Retail Property Fund and Elanor Commercial Property Fund

New 90-day high: AU$1.80

Elanor Healthcare Real Estate Fund, managed by Elanor Investors Group (ASX:ENN) acquired 2 Civic Boulevard property in Rockingham for AUD 22.9 million.

Elanor Investors Group (ASX:ENN) acquired Office Complex in Woolloongabba for for AUD 80.2 million.

Elanor Investors Group Establishes New Managed Fund, the Burke Street Fund

New 90-day high: AU$1.44

Elanor Healthcare Real Estate Fund, managed by Elanor Investors Group (ASX:ENN) acquired Woolloongabba Community Health Centre in Brisbane, Australia for AUD 37.3 million.

New 90-day high: AU$1.20

Riverside Plaza Syndicate fund of Elanor Investors Group (ASX:ENN) acquired Riverside Plaza in Queanbeyan from Vicinity Centres (ASX:VCX) for AUD 60 million.

Price target lowered to AU$1.66

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action